Have been quietly topping up. Am really impressed with the thoroughly professional approach 'management et al' have to getting CxBladder into the medical arena. And also very grateful for the informed comment+ posted in this thread!
Printable View
Have been quietly topping up. Am really impressed with the thoroughly professional approach 'management et al' have to getting CxBladder into the medical arena. And also very grateful for the informed comment+ posted in this thread!
Particularly interested that Cx bladder is being measured against cytoscopy and follow up as the " gold standard". Did I read somewhere amongst this thread that during some tests that cx bladder identified more cancers than that method. Would suggest that Cx bladder has a good chance of being the gold standard if that is the case. Once again thanks for your hard work and for sharing with us, Hancocks
What you may be thinking of Major was one of the very good outcomes from the cxbladder trial carried out in Australia and New Zealand. During the trial, 3 of the patients that initially tested positive with cxbladder, but negative in the clinical work up, later were shown to have bladder cancer.
Detected urothelial carcinoma (4%) not identified by Cystoscopy during the clinical work-up but confirmed by Cystoscopy at the 12 month follow-up.
I would guess that this is an outcome that Pacific Edge is pointing to in getting clinicians on board. I'm sure it's a good way of getting urologists to sit up and take notice of the benefits of using cxbladder.
Will this get them accross the line to purchase?
Seems here's another one getting closer ...
http://www.sciencecodex.com/novel_ge...eatment-116292
The 58 cent support appears to be holding up well, which is nice to see. I do have a small suspicion that someone may be trying to keep the price down (make small trades that push the price down at closing and other weird trades), as was noted by someone a few weeks back. Not really worth over thinking though.